Marks F, Fürstenberger G, Kownatzki E
Cancer Res. 1981 Feb;41(2):696-702.
When applied to mouse skin in vivo, both the strong tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) (2 nmol) and the divalent cation ionophore A 23187 (200 nmol) caused the same responses, i.e., skin inflammation and prostaglandin E2-mediated epidermal hyperplasia. In both cases, these events were accompanied by certain biochemical reactions in the epidermis such as an increase in the biosynthesis of and sensitivity to prostaglandin E2, increase in ornithine decarboxylase and phosphodiesterase activities, and refractoriness of cyclic adenosine 3':5'-monophosphate production to beta-adrenergic stimulation. In contrast to A 23187, TPA did not induce degranulation of mast cells; whereas, in contrast with TPA, A 23187 did not show tumor-promoting activity. These results indicate that the observed biological effects of TPA are no indication of tumor-promoting ability and that, on the other hand, the mitogenic effects of A 23187 are possibly not due to its properties as a calcium ionophore.
当在体内应用于小鼠皮肤时,强效肿瘤促进剂12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)(2 nmol)和二价阳离子载体A 23187(200 nmol)引起相同的反应,即皮肤炎症和前列腺素E2介导的表皮增生。在这两种情况下,这些事件都伴随着表皮中的某些生化反应,如前列腺素E2的生物合成增加和对其敏感性增加、鸟氨酸脱羧酶和磷酸二酯酶活性增加,以及环磷酸腺苷产生对β - 肾上腺素能刺激的不应性。与A 23187相反,TPA不会诱导肥大细胞脱颗粒;而与TPA相反,A 23187没有显示出肿瘤促进活性。这些结果表明,观察到的TPA的生物学效应并不能表明其具有肿瘤促进能力,另一方面,A 23187的促有丝分裂效应可能并非归因于其作为钙离子载体的特性。